Through the agreement, EyePoint’s Yutiq and Dexycu products for eye surgery will be available to 9 million VA beneficiaries and federal employees. The contract will last five years.
“This new agreement with the VA further extends the commercial reach of Dexycu and Yutiq to patients suffering from ocular diseases in areas of high unmet medical need,” said Nancy Lurker, president and CEO of Watertown-Mass.-based EyePoint Pharmaceuticals.
More articles on supply chain:
ASC supply chain tip: Involve everybody in cost-cutting
IT provider for ASCs, hospitals installs nurse as director of operational excellence
Medline, HOTB Software Solutions partner to ease accreditation process
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.